The Hang Seng Index rebounded to 22,000 points last week but remained range-bound as investors unwound positions before the year ends. Only mainland insurance stocks are likely to outperform and heav ...More
EJ Insight2015-12-22
Pharmaceutical giant Pfizer's patent right for the erectile dysfunction (ED) drug Viagra expired in China last month. That puts an end to the 13-year-wait of mainland drug firms who had been eyeing th ...More
EJ Insight2014-08-21
Guangzhou Baiyunshan Pharmaceutical Group Co. Ltd. (600332.CN) has secured endorsement from the Guangdong assets supervision and administration commission to establish a share option mechanism that is ...More
EJ Insight2013-12-31
State-mandated price cuts on essential medicines have led to excessively low margins, discouraging manufacturers and causing a shortage of these drugs. Now the government is moving to put a floor unde ...More
EJ Insight2013-11-18
The National Health and Family Planning Commission is on the march. It has sent out eight teams of inspectors this month to audit public health authorities in 16 provinces, autonomous regions and muni ...More
EJ Insight2013-10-18
